Leif Niclas Fredrik Löwgren
Directeur/Bestuurslid bij Omnivation AB
Actieve functies van Leif Niclas Fredrik Löwgren
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Omnivation AB | Directeur/Bestuurslid | - | - |
Loopbaan van Leif Niclas Fredrik Löwgren
Eerdere bekende functies van Leif Niclas Fredrik Löwgren
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| COPPERSTONE RESOURCES AB | Directeur/Bestuurslid | - | 14-05-2019 |
| NEXTCELL PHARMA AB | Directeur/Bestuurslid | 01-01-2017 | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Directeur/Bestuurslid | 01-01-2017 | - |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Directeur/Bestuurslid | - | - |
Opleiding van Leif Niclas Fredrik Löwgren
| University of Stockholm | Masters Business Admin |
Statistieken
Internationaal
| Zweden | 7 |
Operationeel
| Director/Board Member | 5 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| COPPERSTONE RESOURCES AB | Non-Energy Minerals |
| NEXTCELL PHARMA AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Omnivation AB |
